Let's review moves from smid-cap biopharma companies during this past week. See Table 1 for weekly moves and moves YTD for companies and categories on BPIQ.com compared to XBI. Want stock picks and ideas? Sign up for Amp Bio Pro! Learn more here.
Table 1. BPIQ company weekly moves and YTD moves
Category | Weekly Move 12/26-12/30 | YTD Move |
---|---|---|
BPIQ Index* | 4.59% | -46.93% |
CAR-T Companies | 2.86% | -57.94% |
Gene Editing Companies | 0.29% | -57.99% |
Alzheimer's Disease Companies | 1.73% | -46.60% |
NASH & Liver Disease Companies | 4.05% | -34.90% |
XBI | 2.62% | -25.87% |
*All smid-cap biopharma companies between $50M and $12.5B
See the biggest moves from last week below:
Don't miss upcoming news.. Get our free weekly newsletter
*We never send you spam - unsubscribe anytime
Biggest positive move this week
$KALA 883% IND accepted for Phase 2b trial
Biggest negative move this week
$ACER -32.5% FDA approval of OLPRUVA
Major Weekly Moves and News
Highlights for next week
$VRDN Ph1/2 data
$CTMX Ph1/2 interim data
$BIIB PDUFA
To see the upcoming January Big Movers HERE, subscribe. Learn more here.
See our January PDUFA list
See our Big Movers post to learn about remaining Movers in January and PDUFAs, after subscribing. Learn more here.
Comments